A number of new vaccines will arrive on the market with the purpose to immunize a large number of people against COVID-19 virus. But are all involved parties ready to coordinate their efforts to ensure a ensure a adequate identification of those vaccines? And how can IDMP help to solve this important and now urgent issue ? Come and join the debate. 

This webinar will explore how much IDMP supports the near-future immunizations – from marketing authorisation, labelling, preparedness for adverse event processing and validation, to pharmaco-economic analysis. 

Date: Friday 4 December 2020 

Time: 3:00 – 4:30 pm CET 

Presenters: Mirjam Sturkenboom (VACC4EU) 

Anja van Haren (CBG, WP3) 

Malin Fladvad (WHO-UMC, WP1) 

Panelist:Robert Vander Stichele (University Gent, I~HD, WP 8) 

Moderators:Christian Hay and Robert Stegwee (WP 1) 

ZOOM-link:  Please note that you are requested to register for this webinar using this link  (please do so as soon as possible; if the number of attendees exceeds the maximum of 100, you will receive a link to follow the webinar in streaming mode on youtube; that link will only be sent to registered participants). 

Upon completing your registration you will automatically receive the ZOOM-link and password for this webinar.